Mikhail Blagosklonny is an incredibly well reputed individual in the field of oncological research. He has had an incredibly long career and through this, has brought to life numerous discoveries and treatments that otherwise would not have seen the light of day. His impact on the world of medicine has been so enormous that today, he is considered to be one of the most well-reputed people in the field, especially in oncology. Right from the time, he graduated college, Mikhail Blagosklonny has always been interested in oncology. Oncological research, in particular, was something that he wanted to get into, and therefore decided to join a company known as Ordway, which is an organization that is dedicated to researching and finding new treatments for those diagnosed with this disorder. The company was precisely what Mikhail Blagosklonny was on the lookout for, and proved to be a brilliant place for him to start his career in oncology.
His time at Ordway was spent heavily researching the current treatments that people all around the globe were being given for the treatment of their conditions. Mikhail Blagosklonny saw an incredible amount of success during his time at Ordway, which also paved the way for future endeavors in the sector of oncological medicine. While he was working at Ordway, Mikhail Blagosklonny also started teaching at the New York School of Medicine. He imparted his knowledge of medicine to several batches of students, who all looked up to Mikhail Blagosklonny as a person with an incredible amount of insight into the field. Mikhail Blagosklonny soon discovered that he liked teaching as well as researching, which is why till today, he continues to be an oncology professor. Currently, Mikhail Blagosklonny is the leader of the oncological studies section working for the Roswell Park Cancer Institute and uses his knowledge in the field to guide students who are on their way to becoming doctors, researchers, and surgeons in the field.
One of the most iconic research endeavors that Mikhail Blagosklonny was part of was the study of a drug known as Rapamycin. Rapamycin is a compound that is present in a lot of cancer-treating drugs and showed signs of increasing the longevity of human life. This was an incredible discovery that Mikhail Blagosklonny made, and earned him a considerable amount of recognition in the industry. Since the subject of increasing life expectancy in people is something that not many doctors research about, Mikhail Blagosklonny gave way to new potential studies that could aid human life in the future.
Mikhail Blagosklonny also is the chief editor of a publication that he started known as Oncotarget. Oncotarget is a newsletter that is focused on delivering some of the most current and notable content in oncology to people who are interested in it. This online newsletter has received a lot of support from oncologists all over the world who have chosen this as a medium to keep in touch with the happenings and developments in the oncological field across the globe.